Cargando…
Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women
Statins, also known as HMG-CoA inhibitors, are a class of bioactive small molecules that efficiently reduce the levels of cholesterol, and therefore are commonly used to manage and prevent various cardiovascular diseases. With respect to their original medical indications, statins are currently in t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760915/ https://www.ncbi.nlm.nih.gov/pubmed/33255609 http://dx.doi.org/10.3390/ph13120422 |
_version_ | 1783627445291712512 |
---|---|
author | Markowska, Anna Antoszczak, Michał Markowska, Janina Huczyński, Adam |
author_facet | Markowska, Anna Antoszczak, Michał Markowska, Janina Huczyński, Adam |
author_sort | Markowska, Anna |
collection | PubMed |
description | Statins, also known as HMG-CoA inhibitors, are a class of bioactive small molecules that efficiently reduce the levels of cholesterol, and therefore are commonly used to manage and prevent various cardiovascular diseases. With respect to their original medical indications, statins are currently in the group of the most prescribed drugs worldwide. Of note is that statins are perceived actually rather as agents that have pleiotropic activities; in addition to their inhibitory activity on the production of endogenous cholesterol. Statins may also affect cell proliferation, angiogenesis and/or migration (metastasis) of different cancer cells, and play a positive role in the chemoprevention of cancer, thus being the excellent candidates to be repurposed in oncology. Particularly intriguing in this context seems to be the promising role of statins on both the incidence and course of common malignant neoplasms in women. In this article, we review and discuss the effect of the use of statins in the treatment of three types of cancer, i.e., breast, endometrial and ovarian cancer, with the highest mortality among gynecological cancers. |
format | Online Article Text |
id | pubmed-7760915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77609152020-12-26 Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women Markowska, Anna Antoszczak, Michał Markowska, Janina Huczyński, Adam Pharmaceuticals (Basel) Review Statins, also known as HMG-CoA inhibitors, are a class of bioactive small molecules that efficiently reduce the levels of cholesterol, and therefore are commonly used to manage and prevent various cardiovascular diseases. With respect to their original medical indications, statins are currently in the group of the most prescribed drugs worldwide. Of note is that statins are perceived actually rather as agents that have pleiotropic activities; in addition to their inhibitory activity on the production of endogenous cholesterol. Statins may also affect cell proliferation, angiogenesis and/or migration (metastasis) of different cancer cells, and play a positive role in the chemoprevention of cancer, thus being the excellent candidates to be repurposed in oncology. Particularly intriguing in this context seems to be the promising role of statins on both the incidence and course of common malignant neoplasms in women. In this article, we review and discuss the effect of the use of statins in the treatment of three types of cancer, i.e., breast, endometrial and ovarian cancer, with the highest mortality among gynecological cancers. MDPI 2020-11-25 /pmc/articles/PMC7760915/ /pubmed/33255609 http://dx.doi.org/10.3390/ph13120422 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Markowska, Anna Antoszczak, Michał Markowska, Janina Huczyński, Adam Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women |
title | Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women |
title_full | Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women |
title_fullStr | Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women |
title_full_unstemmed | Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women |
title_short | Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women |
title_sort | statins: hmg-coa reductase inhibitors as potential anticancer agents against malignant neoplasms in women |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760915/ https://www.ncbi.nlm.nih.gov/pubmed/33255609 http://dx.doi.org/10.3390/ph13120422 |
work_keys_str_mv | AT markowskaanna statinshmgcoareductaseinhibitorsaspotentialanticanceragentsagainstmalignantneoplasmsinwomen AT antoszczakmichał statinshmgcoareductaseinhibitorsaspotentialanticanceragentsagainstmalignantneoplasmsinwomen AT markowskajanina statinshmgcoareductaseinhibitorsaspotentialanticanceragentsagainstmalignantneoplasmsinwomen AT huczynskiadam statinshmgcoareductaseinhibitorsaspotentialanticanceragentsagainstmalignantneoplasmsinwomen |